Floral impressionism oil paintings
Antoine Gaber biographie
Galerie du peintre canadien impressionniste Antoine Gaber
ecran de veille artiste peintre impressionniste Antoine Gaber
Revue de presse artiste peintre canadien impressionniste Antoine Gaber
objets de collection de l'artiste peintre impressionniste canadien Antoine Gaber
courrier pour l'artiste peintre impressionniste Antoine Gaber
liens de sites d'art decoratifs

 

Biographie
de l'artiste

Communiqué de presseProchaines expositions

Portrait historique de l'artiste

Expositions
en solo

Expositions
de groupe

Couverture médiatique de l'artiste

Télévision

Valeurs des Tableaux

Avis des Critiques d'art

Avis des écrivains et journalistes

Antoine Gaber

Articles scientifiques

Gao X, Reddy P, Bhardwaj T, Bjarnason G, Finelli A, Kapoor A, Patenaude F, Jaszewski B, and Abugaber, A .COST-EFFECTIVENESS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE IN ADVANCED RENAL CELL CARCINOMA IN CANADA. Proceedings of ASCO, 2007, Abstract # 5111.

Lang K, Danchenko N, Thompson D, Bhardwaj T, Bjarnason G, Finelli A, Kapoor
A, Patenaude F, Jaszewski B and Abugaber, A. COST OF ILLNESS OF RENAL CELL CARCINOMA IN CANADA. Proceedings of ASCO, 2007, Abstract # 32312

Oliver R. Keller, Mark Vincent, Jean Maroun, Anthony Fields, Tarun Wasil, Malcolm Moore, Simone Dahrouge, Remco Donker, Lynn Douglas, Antoine A Abugaber, James Donnelly. Folate Depletion is Associated with Significant Haematological Toxicity in Patients (pts) Treated with Raltitrexed (Tomudex) for Colorectal Cancer. Proceedings of ASCO Volume 20, Part 1 of 2, 2001, p.141a: Abstract # 562 also presented at the General Poster Session / Discussion during ASCO Meeting

Cripps, C., Batist,J., Goel, R., Huan, S., Fry, D., Dahrouge, S., McQuillan, A., Kolendowicz, R., Abugaber, A.A. (2000) Phase I Study of Tomudex (raltitrexed) and Gemcitabine in the Treatment of Advanced Cancer. Annals of Oncology

Hye-Kyung Lee, Jean A. Maroun, Antoine Abugaber, H. Chaim Birnboim. Thymidylate synthase gene polymorphism in a cohort of Canadian colorectal cancer patients (2000)

Goss, G.,Hirte,H.,Batist,G.,Stewart,D.,Miller, W.,Lorimer,I.,Abugaber, A.,Matthews,S.,Seymour,L.
NCIC CTG IND122: A Two-Part Phase I Pharmakokinetics(PK) and Pharmacodynamic(PD) study of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor(EGFR-TKI) ZD 1839
Proceedings of ASCO Volume 19, 2000, p.225a : Abstract # 880

Keller, O.,Vincent, M., Maroun, J.,Fields, A., Wasil, T.,Moore, M.,Dahrouge, S.,Douglas, L., Abugaber, A High Dose Raltitrexed (Tomudex) has manageable Toxicity Profile in Patients with Advanced Colorectal Cancer. Proceedings of ASCO Volume 19, 2000, p.283a : Abstract # 1107

Nguyen, P. Dube, Y.E. Leclerc, C. Emond, A. A. Abugaber, sPreliminary Results of Pharmacological Studies and Toxicity Profile of Raltitrexed after Intraperitoneal Administration in Normothermy in Pigs. (September 1999) Royal College of Canada Abstract

C Cripps, G Batist, S Dahrouge, D Fry, A McQuillan, R Kolendowicz, AA Abugaber
A Phase I Study of TOMUDEX® and GEMCITABINE® (G) in Advanced Cancer. The European Journal of Cancer Volume 35 Supl. 4 P S289 (September 1999) Abstract 1162

G. Bjarnason, D. Charpentier, R. Wong, R. Goel, M. Smith, A. Abugaber, S. Matthews, L. Seymour. NCIC CTG IND 98 : A Phase I Dose Escalation Study of Raltitrexed (Tomudex®) Plus Doxorubicin (DOX) in Patients with Advanced Cancer. The European Journal of Cancer Volume 35 Supl. 4 P S290 (September 1999) Abstract 1164

J. Maroun, C. Cripps, R. Goel, D. Jonker, S. Dahrouge, L. Pigeon, R. Kolendowicz, A.A. Abugaber A Phase I of Raltitrexed (Tomudex®) and Irinotecan in Metastatic Colorectal Cancer. Cancer Prevention & Control, 1999; 3 (2 Supplement); p. 1,

C Cripps, G Batist, S Dahrouge, D Fry, A McQuillan, R Kolendowicz, A.A. Abugaber ,
A Phase I Study of Tomudex ® (T) + Gemcitabine (G) in Advanced Cancer. Proceedings of ASCO Volume 18, 1999, p.207a : Abstract # 796

R. P. Wong, G. Bjarnason, D. Charpentier, E Winquist, A. Abugaber, S. Matthews.
Raltitrexed (Tomudex®) Plus Doxorubicin (DOX) in Patients with Advanced Cancer: Results of a Phase I Dose Escalation Study. Proceedings of ASCO Volume 18, 1999, p.232a : Abstract # 896

M Vincent, O Keller, J Maroun, R Wong, M Moore, A Fields, S Dahrouge, L Douglas, AA Abugaber, A Phase II Study of Higher Dose (3.5 mg/m2) TOMUDEX® (raltitrexed) in Advanced Colorectal Cancer. Proceedings of ASCO Volume 18, 1999, p.289a : Abstract # 1108

D. Nguyen, P. Dube, Y.E. Leclerc, C. Emond, A. A. Abugaber,
Preliminary Results of Pharmacological Studies and Toxicity Profile of Raltitrexed after Intraperitoneal Administration in Normothermy in Pigs. Canadian Journal of Surgery (September 1999)
Maroun, J., Cripps, C., Goel, R., Jonker, D., D., Dahrouge, S., Pigeon, L., A., Kolendowicz, R., Abugaber, A.A. (1999) A Phase I of Raltitrexed (Tomudex and Irinotecan in Metastatic Colorectal cancer. Cancer Prevention & Control vol. 3: (2), Suppl:1 p.1

Batist, G., Trudeau, M., Patenaude, F., Zukiwski, A., Ricci, S., Joyce, L.J., Langlaben, A., Ahlgren, P., Gruner, P., Ross, A., Mitter, S., Abugaber, A., Frost, H. (1999) Phase I Study of MTP-PE Plus 5-Fluorouracil and Leucovorin in Patients with Metastatic Colorectal Cancer.
Journal of Clinical Oncology .

Krajden., M., Abugaber, A., Stotter, H., Wong, P.Y., Wong.,L., Grigoriew, GA.,
Detection of Hepatitis B virus DNA (HBV DNA) by the Chiron HBV DNA Branched Chain Assay (CBHBV-DNA) and the Abbott HBV DNA Assay (AHBV-DNA) in Sequential Serum Samples from Interferon Patients (1995). Journal of Microbiology (abstract presented at the American Society for Microbiology).

Phase 1 Study of MTP-PE Plus 5-Fluorouracil and Leucovorin in Patients with Metastatic Colorectal Cancer (Clinical Trial Report).1995

Lalague, E.D., Abugaber, A.A., Haviernick, S., Corvellec, M.R., Pelletier, L., Derghazarian, C., Cousineau, G.H. (1982). SEM observation of cultured, Mitogen-stimulated Leukocytes. Cells obtained from patients with acute Myeloblastic and chronic Lymphocytic Leukemia.
Experientia 38 (1): 90-92.

Abugaber, A.A., Lalague, E.D., Roy, A., Champagne, M.R., Cousineau, G.H. (1981).
The use of various buffers in the Preparation of Human Lymphocytes for SEM observation.
Journal of Microscopy, 122: Pt 1: 59-64.

Abugaber, A.A., Lalague, E.D., Champagne, M.R., Cousineau, G.H.,
Observation of Human Cells by SEM: detailed study of buffers preparation (in French). Association Canadienne-française pour l'avancement des sciences (1980), 48 ème Congrès, Annales de l'ACFAS, vol. 47: no. 1, p. 18.

Lalague, E.D., Abugaber, A.A., Cousineau, G.H., Scanning Electron Microscopy: Leucocytes observation. Association Canadienne-francaise pour l'avancement des sciences (1980),
48 ème Congrès, Annales de l'ACFAS, vol. 47: no. 1, p. 18.


Lalague, E.D., Abugaber, A.A., Martin, S.J.C., Gaulin, R.E., Cousineau, G.H., (1979).
Preparation of Human Leukocytes for SEM Observation: a modified technique,
Canadian Review of Biology, 38: 195-199.

Lalague. E.D., Abugaber, A.A., Haviernick, S., Corvellec, M.R., Cousineau, G.H.,
Molecular Biology practical works. University of Montréal Press, Province of Québec, Canada (1979, 1980, 1981, 1982, 1983 editions).
 

Biographie de l'artiste | Portrait historique de l'artiste | Expositions en solo | Expositions de groupe | Passion pour la vie | Prochaines Expositions | Communiqués de presse |Couverture médiatique de l'artiste | Télévision | Valeurs des Tableaux | Avis des Critiques d'art | Avis des écrivains et journalistes | Galerie Gaber | Courrier de l'artiste | Objets de collection | Écran de veille | Retour au Menu principal
© 1995- Antoine Gaber Artiste Peintre Impressionniste , tous droits réservés.
Propriété intellectuelle : les oeuvres apparaissant sur ce site sont la propriété de l'artiste et toute reproduction à but lucratif sans permission écrite est une violation à la Loi internationale de la propriété intellectuelle et de celle des Etats-Unis.